Drawing for ENLIGHTEN

USPTO serial 76236936

ENLIGHTEN

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
WELLS, CHRISTOPHER
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENLIGHTEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberta Jacobs-Meadway

1735 MARKET ST FL 51PHILADELPHIA, PA 19103-7501UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003aromatherapy products, namely gels, lotions, powders and liquids for use in pools, spas, hot tubs, baths and jetted bathsABANDONEDJan 10, 2001

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 14, 2003ABN5ABANDONMENT - AFTER PUBLICATION—
Dec 6, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 27, 2002MAILPAPER RECEIVED—
Nov 5, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2002NPUBNOTICE OF PUBLICATION—
Sep 3, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2002DOCKASSIGNED TO EXAMINER—
Oct 25, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 27, 2001CNSLLETTER OF SUSPENSION MAILED—
Jul 23, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance